GB2250286A - Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines - Google Patents
Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines Download PDFInfo
- Publication number
- GB2250286A GB2250286A GB9111896A GB9111896A GB2250286A GB 2250286 A GB2250286 A GB 2250286A GB 9111896 A GB9111896 A GB 9111896A GB 9111896 A GB9111896 A GB 9111896A GB 2250286 A GB2250286 A GB 2250286A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compound
- formula
- product
- viii
- zinc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic System
- C07F1/02—Lithium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
- C07F3/06—Zinc compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Description
2250236 CHEMICAL PROCESS This invention relates to a process for the
preparation of 2-phenyl-6- (pyrimidin-2-yl)pyridine derivatives, to intermediate compounds used therein and to processes for preparing the intermediate compounds.
According to the present invention there is provided a process for the preparation of a compound of formula (V), wherein V, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy, the process comprising treating a compound of formula (IV), wherein Wt Y and Z are as defined above, with zinc (II) chloride.
In one aspect the present invention provides a process for the preparation of a compound of formula (V), wherein V, Y and Z are as defined above, the process comprising the steps of: a) lithiating a compound of formula (VIII), where W, Y and Z are as defined above and X is bromine or iodine; and, b) treating the product formed in (a) with zinc (II) chloride.
In another aspect the present invention provides a process for the preparation of a compound having the general formula (1), wherein W; Y and Z are as defined above, R 1, R 2 and R 3 are independently hydrogen, alkyl, haloalkyl or alkoxy and R 4, R 5 and R6 are independently hydrogen, chlorine, fluorine, alkyl, haloalkyl or alkoxy, or R 4 and R 5 together form a polymethylene group of the formula -(CH 2)m- in which m is 3 or 4; the process comprising the steps of: a) lithiating a compound of formula (VIII), wherein X, V, Y and Z are as defined above; b) treating the product so formed in (a) with zinc (II) chloride; and c) reacting the product so formed in (b) with a compound of formula (III), in the presence of a suitable catalyst.
The invention includes the steps (b) and (c) individually or in combination.
The process is particularly useful for the preparation of compounds having the general formula (I) wherein W, Y, Z, R 1, R 2, R 3, R 5 and R 6 are all hydrogen and R 4 is methyl.
A suitable compound of formula (VIII) is 2-chlorobromobenzene.
Alkyl and the alkyl moieties of alkoxy and haloalkyl groups contain from 1 to 6, preferably 1 to 4, carbon atoms and are either straight or branched chain groups, for example, methyl, ethyl, n-propyl, iso-propyl, nbutyl, iso-butyl, sec-butyl or tert-butyl- Compounds having the general formula (I) are disclosed in (EP-A-259139) and are useful as fungicides.
The process of the invention is shown in Scheme A. Throughout Scheme A the variables W, Y, Z, X, R I, R 2, R 3, R 4, R 5 and R6 are as defined above.
In step (a) a compound of formula (VIII) is lithiated preferably with an alkyl lithium (for example n-butyl lithium) in a suitable solvent (such as tetrahydrofuran) at a suitable temperature (such as -70 to -1000C, preferably -70 to -78C) to give a product (IV). It is believed that product (IV) has the general formula (IV).
In step (b) the product formed in step (a) (product (IV)) is reacted with zinc (II) chloride in a suitable solvent (for example diethylether) at a suitable temperature (such as in the range -60 to -80C, preferably in the range -70 to -78C) to give a product (V). It is believed that product (V) has the general formula (V).
In step (c) product (V) is reacted with a compound of general formula (III) in the presence of a suitable catalyst (for example tetrakis(triphenylphosphine) palladium.0) in a suitable solvent (for example tetrahydrofuran) and at a suitable temperature.
Compounds of general formula (III), in which R 1, R 2, R 3, R 4, R 5 and R 6 are as defined above, can be prepared by coupling together a dibromopyridine of general formula (VI), wherein R I, R 2 and R 3 are as defined above, with a bromopyrimidine of general formula (VII), wherein R 4 R 5 and R 6 are as defined above. The coupling reaction can be carried out by treating the dibromopyridine (VI) with normal butyl lithium in tetrahydrofuran followed by zinc (II) chloride in diethylether, and then adding tetrakis(triphenylphosphine)palladium with the bromopyrimidine (VII). The reaction is carried out at temperatures of between -70 and 20C.
In a further aspect the present invention comprises the product of the process comprising the steps of: a) lithiating a compound of formula (VIII), wherein X, V, Y and Z are as defined above; and, b) taking the product so formed and reacting it with zinc (II) chloride.
In another aspect the present invention comprises the product of the process of treating a compound of formula (IV), wherein W, Y and Z are as defined above, with zinc (II) chloride.
In a still further aspect the present invention comprises a compound having the general formula (V).
j The following Example illustrates the present invention. Where shown, NMR data are selective; no attempt is made to list every absorption. The following abbreviations are used throughout:
THF = tetrahydrofuran dd = doublet of doublets d = doublet t = triplet S = singlet EXAMPLE 1 This Example illustrates the preparation of 4-methyl-2-(6-(2- chlorophenyl)pyrid-2-yl)pyrimidine, as shown in Scheme B. Reactants 2- chlorobromobenzene (Aldrich) 0.57g (2.98mM) n-butyl lithium 2.5M in hexanes (Aldrich) 1.7ml (4.27mM) zinc (II) chloride LOM in ether (Aldrich) 10ml (lOmM) 4-methyl-2-(6-bromopyrid-2-yl)pyrimidine 0.5g (2mM) tetrakis(triphenylphosphine)palladium 0.05g (catalyst). Method 2-Chlorobromobenzene (dried over molecular sieve 4A) was dissolved in tetrahydrofuran (10ml - freshly distilled from sodium and benzophenone) in dry apparatus under an atmosphere of nitrogen. The resulting solution was then cooled, with stirring, (using a solid CO 2 /acetone bath) to - 78C and a solution of n-butyl lithium was added over 15 minutes at a temperature below 70'C. The colourless solution was then stirred at -78C for 15 minutes before adding the anhydrous zinc (II) chloride solution at below -70C over a period of 20 minutes. The resultant white suspension was stirred at -780C for 30 minutes before adding a solution of 4-methyl2-(6bromopyrid-2-yl) pyrimidine and tetrakis(triphenylphosphine)palladiumO in THF (10ml freshly distilled from sodium/benzophenone). The reaction mixture was then allowed to warm up to room temperature to give a pale yellow solution, from which a white solid began to precipitate. The mixture was then heated to reflux for 30 minutes before cooling and quenching by the addition of a 10% aqueous solution of ethylene diamine tetra acetic acid sodium salt (150ml at pH8). The two layers were seperated and the aqueous solution was extracted with ethyl acetate (2x5Oml). The organic solutions were combined, dried over magnesium sulphate (anhydrous) and evaporated to give a bright yellow gum - yield 0.9g. The gum was purified by flash vacuum chromatography through a 40mmx4Omm diameter plug of silica gel (Merck 7729) eluting with 1x50C dichloromethane then 4x50m1 portions of methyl-t-butyl ether. Fractions 3 to 5 were combined to give a pale yellow gum. Yield 0.397g (70.5%), which solidified on standing. The solid was recrystallised from 10% ethyl acetate in hexane to give lustrous white plates. Mpt. 123.8 - 124.PC. Proton NMR in CDC1 3 at 270 MHz: 7.47(dd); 7.36(m); 7.77(d); 7.92(t); 8. 48(d); 8.79(d); 7.28(d); 2.66(s) ppm. Synthesis of 4-methyl-2-(6bromapyrid-2-yl)pyrimidine 2,6-Dibromopyridine (9.48g, 40mM) was dissolved in tetrahydrofuran (100m1 freshly distilled from sodium/benzophenone) under nitrogen. The solution was then cooled in a solid CO 2 /acetone bath and n-butyl lithium (2.5 molar solution in hexane - 24m1 60mM) was added with stirring over 30 minutes at below -700C. The dark green solution was then stirred at -780C for 1 hour after which time a small sample was removed, quenched by addition of water and extracted with ethyl acetate. Gas chromatography analysis showed only 2-bromopyridine to be present. At this point an anhydrous solution of zinc (II) chloride (1.0 molar in diethylether 120m1 120mM) was added over 30 minutes with the reaction temperature below - 701C. During the addition the colour became a paler green and a green gum precipitated. A solution of tetrakis(triphenylphpsphine)palladium (1.Og catalyst) and 2-bromo-4-methylpyrimidine (9.6g, 39.9mM) in tetrahydrofuran (100C freshly distilled from sodium/benzophenone) was then added over 30 minutes at below -701C. The reaction mixture was allowed to warm up to room temperature before refluxing for 1 hour. After cooling to room temperature the reaction was quenched by pouring into a 10% solution of sodium ethylene diaminetetraacetate in water at pH8 (500m1) and extracting with ethyl acetate (3x500m1). The combined ethyl acetate extracts were washed once with water (100m1), dried over magnesium sulphate and evaporated to give a brown gum (12.1g).
The gum was purified by medium pressure preparative liquid chromatography using silica gel 60 (40-60 micron) and eluting with ethyl acetate to give the product as a pale brown solid. Yield 3.15g (31.5%) The solid was recrystallised from ethyl acetate m.pt 134.5 to 135.10C N.M. R. proton shifts in CDC1 3 at 270 MHz: 7.60(dd); 7.71(t); 8.46(dd); 8. 78(d); 7.19(d); 2.76(s) ppm.
CHEMICAL FORMULAE (in description) cl v 1 -:,, y z R 1 R 2 R 3 4 N NN R R (I) R 6 X cl Z', 1 ";;- W y R R 3 N N Br N R 4 R 5 R 6 (VIII) (III) - 6 CHEMICAL FORMULAE (in description)
Li cl 1 ZJO v ZnCl cl 1 z 'i y R2 R 1 1 N Br B 6 R -/ - N \, N - R1 5 Br (IV) (VI) (Vii) Scheme A X 1 cl ---- li::
y V U, Product (IV) W Product (V) y (Viii) step (a) step (b) R 21 step (c) 1 ', R 3 cl ";" 1 W N N (I) 1 1-t.1 1 1 11 N, - R 5 R 6 z (I) R 4 Scheme B Br 6"Z -- 1 cl n-BuMITHF 1 1011 4 cl1. "- N "-' -- 17-N :' 1 N - Z:-1 1 (1 1.5 Li cl zncl 2 /diethylether -700c CH 3 ZnCl cl 5::P, 1/ :-11 t,'
Claims (8)
1. A process for the preparation of a compound of formula (V):
ZnCl %0 1 cl 1 Z / V Y (V) wherein W, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy, the process comprising treating a compound of formula (IV):
Li 0111, 1 Cl Z Z I W j I Y (IV) wherein W, Y and Z are as defined above, with zinc (II) chloride.
2. A process as claimed in claim 1 for the preparation of a compound of formula (V):
ZnCl ---- 1 cl Z W Y (V) wherein W, Y and Z are as defined in claim 1, the process comprising the steps of:
a) lithiating a compound of formula (VIII):
X 1 "R cl 1 li:
Z j v Y (VIII) wherein W, Y and Z are as defined in claim 1 and X is bromine or iodine; and b) treating the product formed in (a) with zinc (II) chloride.
A process for the preparation of a compound having the general formula (I):
cl v 1 Y R 1 R 2 R
3 N N R
4 N R (I) R 6 wherein W, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy, R', R 2 and R3 are independently hydrogen, alkyl, haloalkyl or alkoxy and R 4, R 5 and R 6 are independently hydrogen, chlorine, fluorine, alkyl, haloalkyl or alkoxy, or R 4 and R5 together form a polymethylene group of the formula -(CH2)m- in which m is 3 or 4; the process comprising the steps of: a) lithiating a compound of formula (VIII):
X cl Z', 1 'I 11 Y (VIII) Z 11 - wherein W, Y and Z are as defined above and X is bromine or iodine; b) treating the product so formed in (a) with zinc (II) chloride; and c) reacting the product so formed in (b) with a compound of formula (III):
R 2 R 1 R 3 1 Br N N R 4 Q;Z 1 N - R 5 R 6 in the presence of a suitable catalyst.
(III) A process as claimed in claim 1, 2 or 3 wherein W, Y and Z are all hydrogen.
5. The product of the process comprising the steps of: a) lithiating a compound of formula (VIII):
X cl Z "" 11 1 V Y (VIII) wherein W, Y and Z are independently hydrogen, chlorine, fluorine, alkyl or alkoxy; and X is chlorine or bromine; and, b) taking the product so formed and reacting it with zinc (II) chloride.
6. A compound having the general formula (V):
ZnCl cl 1 Z 11 Y (V) wherein V, Y and Z are independently hydrogen, fluorine, chlorine, alkyl or alkoxy.
The product of the process comprising treating a compound of formula (IV):
1 1 cl Z W Li (IV) Y wherein W, Y and Z are as defined in claim 1, with zinc (II) chloride.
8. A proress as claimed in claim 3 substantially as hereinbefore described with reference to Example 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909012974A GB9012974D0 (en) | 1990-06-11 | 1990-06-11 | Chemical process |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9111896D0 GB9111896D0 (en) | 1991-07-24 |
GB2250286A true GB2250286A (en) | 1992-06-03 |
Family
ID=10677407
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB909012974A Pending GB9012974D0 (en) | 1990-06-11 | 1990-06-11 | Chemical process |
GB9111896A Withdrawn GB2250286A (en) | 1990-06-11 | 1991-06-03 | Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB909012974A Pending GB9012974D0 (en) | 1990-06-11 | 1990-06-11 | Chemical process |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPH04243875A (en) |
KR (1) | KR920000767A (en) |
DE (1) | DE4118430A1 (en) |
FR (1) | FR2663032A1 (en) |
GB (2) | GB9012974D0 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019815A1 (en) * | 1999-09-13 | 2001-03-22 | Sankio Chemical Co., Ltd. | Novel 2-(2-pyridyl)pyrimidine derivatives |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19636994A1 (en) * | 1996-09-12 | 1998-03-19 | Basf Ag | Process for the preparation of (2'-fluorophenyl) -3-halopyridines |
GB9626635D0 (en) * | 1996-12-21 | 1997-02-12 | Zeneca Ltd | Zinc reagent and synthesis |
KR101008075B1 (en) * | 2008-06-27 | 2011-01-13 | 주식회사 포스코 | method for reducing coil break of hot strip |
EP2914587A1 (en) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Novel heterocyclic compounds as pest control agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH23565A (en) * | 1986-09-05 | 1989-08-25 | Sumitomo Chemical Co | Novel pyrimidinylpyrimidine derivatives and a plant disease protectant containing them as the active ingredient |
-
1990
- 1990-06-11 GB GB909012974A patent/GB9012974D0/en active Pending
-
1991
- 1991-06-03 GB GB9111896A patent/GB2250286A/en not_active Withdrawn
- 1991-06-05 DE DE4118430A patent/DE4118430A1/en not_active Withdrawn
- 1991-06-07 KR KR1019910009373A patent/KR920000767A/en not_active Application Discontinuation
- 1991-06-10 FR FR9107025A patent/FR2663032A1/en active Pending
- 1991-06-11 JP JP3138741A patent/JPH04243875A/en active Pending
Non-Patent Citations (2)
Title |
---|
CA 102 (3): 24791j * |
CA 113 (25): 23164h * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019815A1 (en) * | 1999-09-13 | 2001-03-22 | Sankio Chemical Co., Ltd. | Novel 2-(2-pyridyl)pyrimidine derivatives |
Also Published As
Publication number | Publication date |
---|---|
KR920000767A (en) | 1992-01-29 |
DE4118430A1 (en) | 1991-12-12 |
FR2663032A1 (en) | 1991-12-13 |
GB9111896D0 (en) | 1991-07-24 |
JPH04243875A (en) | 1992-08-31 |
GB9012974D0 (en) | 1990-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2562216C (en) | Process for producing a trifluoro-3-buten-2-one compound | |
CN102482504B (en) | Second nonlinear optic compound and containing its nonlinear optical element | |
SU999971A3 (en) | Process for producing derivatives of pyrimidone-4 or their acid addition salts | |
CS259894B2 (en) | Method of substituted nicotinates preparation | |
KR20150064747A (en) | A process for the preparation of acylphosphanes | |
US5541329A (en) | Intermediates prepared in an asymmetric total synthesis of camptothecin analogs | |
US7687632B2 (en) | Process for the preparation of pyridine derivatives | |
CN110790763A (en) | Process for preparing pyridobipyrimidine and pyridobipyrazole derivatives | |
CN107501242B (en) | D-pi-A type dipyrrole fluorescent dye and synthetic method thereof | |
Krutosikova et al. | Condensed O-, N-heterocycles by the transformation of azidoacrylates | |
GB2250286A (en) | Aromatic zinc compound and their use in the preparation of phenylpyridylpyrimidines | |
SA91110352B1 (en) | An improved process for the preparation of substituted endolone derivatives | |
RU2261861C1 (en) | Method for preparing 4-amino-2,5-bis-heterocyclylquinazolines | |
GB2467012A (en) | Lanthanide (III) ion complexing compounds, luminescent lanthanide (III) ion complexes and use thereof as fluorescent labels | |
Sato et al. | The synthesis of azoniadithia [6] helicenes | |
Azadi-Ardakani et al. | 2, 2-Disubstituted-1, 2-dihydro-3 H-indol-3-ones by base-and thermal-induced cyclisations of o-azidophenyl s-alkyl ketones and o-azidobenzoyl esters | |
Björk et al. | Improved syntheses of thieno [2, 3‐b]‐and [3, 2‐b]‐fused naphthyridines | |
Bátori et al. | Synthesis and regiospecificity in methylation of pyrido [1, 2‐a] pyrazinium‐1‐and 3‐olates and pyrido [1, 2‐b] pyridazinium‐2‐and 4‐olates | |
Tanaka et al. | Synthesis of 4H‐furo [3, 2‐b] indole derivatives A new heterocyclic ring system | |
CN110386903B (en) | Tetrazine-containing oligomeric phenylene acetylene compound and preparation method thereof | |
Razus et al. | Azulene‐substituted pyranylium salts. Syntheses and products characterization | |
Lepifre et al. | Synthesis of 4H-pyrido [3, 2-b][1, 4] oxazine and 3-substituted-4H-pyrido [3, 2-b][1, 4] oxazines via palladium-catalysed reactions | |
Croisy-Delcey et al. | Aza analogs of lucanthone: synthesis and antitumor and bactericidal properties | |
Elgemeie et al. | Activated nitriles in heterocyclic synthesis: A novel synthetic route to furyl-and thienyl-substituted pyridine derivatives | |
EP0062068B1 (en) | N-phthalidyl-5-fluorouracil derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |